Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC092143.1		ENSG00000198211			16	89919165-89936092	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"testis: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SK-MEL-30: 19.0"									"CAB011512, HPA043640, HPA046280"	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB011512: AB_444319, HPA043640: AB_2678594, HPA046280: AB_2679612"					"unprognostic (2.90e-4)"				"unprognostic (6.87e-2)"									0.4	0.2	0.2	0.1	0.8	0.3	0.1	0.4	0.7	1.0	0.5	0.6	0.0	0.1	1.2	0.9	1.0	0.7	1.5	1.8	0.2	0.4	0.1	1.3	0.4	0.1	0.9	0.4	4.0	0.2	0.1	0.7	1.4	2.0	2.6	0.1	0.3	0.1	0.1	0.6	5.1	0.4	0.5	2.8	0.6	0.1	10.9	0.2	0.0	0.3	0.0	0.1	1.0	5.1	0.1	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.3	0.2	0.8	0.4	0.7	0.2	0.4	0.9	0.4	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;ovary: 59.4"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		9100	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	14.2	5.0	4.9	1.0	9.8	0.8	8.5	1.5	19.7	4.1	1.8	2.4	0.3	1.2	5.2	1.8	1.6	3.6	2.6	5.9	15.4	4.0	4.5	1.5	1.7	2.8	4.1	14.3	59.4	2.0	1.5	1.3	1.5	23.7	5.4	1.4	3.0	1.6	1.8	1.9	2.1	1.5	6.6	1.4	0.8	1.4	1.9	0.5	0.0	2.9	0.5	1.0	1.9	4.7	0.3	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	3.3	0.0	1.4	0.4	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	1.3	0.0	0.0	0.0	28.6	1.4	5.8	0.0	0.7	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.9	9.8	1.5	19.7	15.4	4.0	4.1	14.3	23.7	0.5	0.0	0.0	0.0	0.2	0.5	0.7	5.3	0.0	5.3	1.2	3.5	0.0	0.2	1.7	0.0	17.1	0.7	0.0	0.0	0.2	0.0	1.6	5.3	0.0	0.0	0.1	0.0	0.0	3.1	0.8	10.8	25.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.9	3.7	0.0	6.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315345	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.3;lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in some"	11	"granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	13.6	6.6	7.0	32.0	9.2	24.2	7.6	1.5	4.2	2.9	5.0	7.0	0.9	4.1	3.9	6.5	3.2	5.5	8.3	9.2	4.7	3.7	5.1	4.5	14.8	27.4	10.3	2.6	2.5	3.1	1.1	3.7	13.5	6.9	4.0	4.8	4.6	10.3	2.1	2.1	3.0	13.2	6.0	9.9	53.9	5.4	2.3	7.5	12.9	3.6	2.9	22.9	12.0	3.2	8.0	27.2	52.3	31.4	11.4	15.1	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.1	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	3.5	0.0	0.0	0.0	12.1	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.4	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.3	1.3	1.6	6.9	4.1	0.1	3.7	15.6	21.6	15.1	26.4	10.6	7.8	8.3	11.9	12.4	8.0	8.0	10.6	52.3	11.4	31.4	27.2	7.5	16.1	7.0	9.2	1.5	4.2	4.7	3.7	10.3	2.6	6.9	7.5	3.0	12.5	18.1	0.7	2.2	0.0	1.6	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.6	2.1	0.3	55.4	0.8	64.0	0.0	0.0	2.5	57.8	0.0	0.6	83.4	6.8	1.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	1.9	0.8	48.9	0.0	0.6
FAN1	"KIAA1018, MTMR15"	ENSG00000198690	"FANCD2 and FANCI associated nuclease 1"	Q9Y2M0	15	30903852-30943108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048198			Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA048198: AB_2680311"	"unprognostic (7.18e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.30e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.67e-2)"	"prognostic favorable (1.42e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.29e-1)"	5.9	8.9	11.6	6.9	17.4	6.3	12.7	19.6	18.4	15.0	11.4	17.7	11.9	4.6	11.6	22.9	6.5	8.5	8.5	13.0	12.6	11.0	14.7	14.4	6.9	5.5	18.5	11.8	12.5	18.2	7.2	17.0	10.6	15.4	16.4	9.7	8.6	17.3	8.3	16.8	9.3	6.7	11.5	13.0	7.3	8.5	9.4	15.0	5.1	14.3	6.3	5.8	9.0	9.1	4.0	3.6	0.6	1.7	4.5	5.4	1.6	6.3	10.9	3.6	2.0	12.9	11.5	2.4	4.5	1.9	4.8	5.0	7.5	3.3	1.4	8.0	4.8	10.0	12.9	6.1	9.4	4.7	5.1	2.9	1.1	11.2	1.3	5.6	0.9	6.1	3.4	7.0	2.9	7.6	10.4	2.3	6.6	5.4	10.0	7.8	1.4	9.9	4.4	2.8	10.2	2.5	8.4	11.8	2.7	7.0	5.0	8.3	5.8	9.9	6.8	3.5	13.6	6.1	7.6	8.2	15.0	3.6	4.1	5.7	13.8	9.6	1.7	6.5	4.8	1.3	0.1	0.8	0.6	3.7	1.3	4.7	2.8	3.5	1.7	2.7	4.0	5.4	2.8	0.3	4.5	1.7	3.6	3.2	1.6	11.6	17.4	19.6	18.4	12.6	11.0	18.5	11.8	15.4	15.0	14.9	9.6	0.8	4.9	3.7	20.0	15.7	0.0	16.0	13.6	8.7	19.6	5.5	8.3	3.3	8.7	6.7	3.8	0.0	2.5	1.8	3.5	4.6	8.1	11.0	3.2	25.4	7.5	8.0	4.1	5.8	9.8	4.1	5.0	2.8	9.7	14.7	3.3	2.9	6.3	5.1	24.3	6.5	4.2	19.5	12.9	2.0	3.4	6.9	8.3	3.1
GSTM5		ENSG00000134201	"Glutathione S-transferase mu 5"	P46439	1	109712255-109775428	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"breast: 237.6;ovary: 66.1"	"Group enriched"	"Detected in many"	6	"Leydig cells: 132.9;Muller glia cells: 217.3;Peritubular cells: 119.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;T-cells: 1.9"	"Group enriched"	"Detected in some"	7	"fHDF/TERT166: 18.0;HHSteC: 7.7;HSkMC: 8.3"									"HPA048652, HPA055972, HPA055973"	Approved		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"unprognostic (1.46e-2)"	"unprognostic (8.64e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.34e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.39e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.40e-1)"	5.8	3.5	25.7	2.6	23.4	1.6	237.6	15.8	24.6	27.2	4.2	14.0	4.7	2.1	14.0	12.0	4.8	19.8	9.0	4.8	24.9	6.2	2.9	2.1	5.7	2.6	4.9	17.9	66.1	2.7	1.6	2.7	1.6	8.9	12.8	4.0	23.0	3.9	11.9	2.4	3.7	3.5	9.8	11.0	3.5	3.9	5.1	11.9	0.0	2.6	2.1	3.2	10.5	16.1	0.0	5.7	0.6	0.2	0.7	1.9	0.9	0.0	0.0	0.0	0.0	1.6	1.6	0.3	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.2	0.0	0.7	0.0	5.7	1.9	0.9	25.7	23.4	15.8	24.6	24.9	6.2	4.9	17.9	8.9	11.9	0.0	0.3	0.0	0.5	6.0	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	8.2	0.8	0.0	0.0	0.0	0.1	12.3	0.1	0.0	0.0	0.2	0.0	0.0	7.4	1.2	9.9	132.9	0.6	10.1	0.0	0.0	217.3	0.0	0.0	119.5	0.0	5.8	25.8	7.6	1.9	1.1	5.6	0.0	0.0	0.0	0.1
HIGD1B	"CLST11240, CLST11240-15"	ENSG00000131097	"HIG1 hypoxia inducible domain family member 1B"	Q9P298	17	44846353-44850480	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 61.8"	"Group enriched"	"Detected in some"	32	"Sertoli cells: 750.3;Smooth muscle cells: 198.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079501			Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA079501: "	"unprognostic (6.85e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (2.07e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.98e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.23e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.52e-2)"	6.4	0.7	12.4	0.7	18.2	0.6	3.2	4.5	9.7	5.7	1.9	3.6	0.4	1.5	6.4	7.6	2.5	3.1	7.1	11.0	12.4	10.1	2.6	0.6	21.6	1.7	15.8	6.8	2.0	2.0	2.5	0.3	61.8	8.7	3.6	1.0	0.7	1.3	4.4	7.9	1.3	1.3	7.3	6.2	0.4	1.5	1.2	8.9	0.1	3.4	1.8	1.1	3.0	1.6	1.1	3.3	4.6	2.9	1.9	3.5	1.1	0.5	1.8	0.0	2.0	0.0	0.0	1.8	1.7	0.0	0.0	0.0	1.0	0.6	1.7	0.5	0.0	0.1	0.7	0.0	0.0	0.0	1.4	2.0	0.4	2.1	1.3	0.0	2.6	3.7	0.0	0.0	0.0	0.0	0.6	0.0	2.6	2.1	1.5	0.0	0.7	1.9	2.0	1.3	0.7	1.0	2.2	1.2	2.5	0.0	1.3	2.2	1.0	0.6	0.0	0.3	0.1	0.9	1.1	0.0	1.8	0.6	1.2	1.4	1.3	3.9	2.0	1.6	3.1	2.2	4.6	1.9	0.7	3.5	2.9	1.3	0.7	2.3	2.6	3.3	1.1	2.5	2.3	0.0	1.9	0.3	0.9	2.0	1.1	12.4	18.2	4.5	9.7	12.4	10.1	15.8	6.8	8.7	8.9	0.0	0.3	0.0	0.5	3.1	0.4	3.9	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.1	14.7	0.0	0.0	0.0	0.2	2.0	0.3	0.0	0.0	0.6	1.6	0.0	1.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.5	750.3	198.1	0.0	0.2	2.0	0.2	0.0	0.0	0.7
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 231.4"	"Group enriched"	"Detected in some"	23	"Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 36.4;SuSa: 16.3"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"			"unprognostic (1.53e-1)"				"unprognostic (7.11e-2)"					"unprognostic (1.15e-1)"		"unprognostic (1.04e-1)"			"prognostic favorable (4.59e-5)"	0.1	0.6	0.0	0.0	0.3	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	231.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.5	11.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	4.0	0.4	0.5	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	115.9	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.8	0.0	0.0	0.0
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 223.2"	"Cell type enhanced"	"Detected in some"	17	"Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Region enriched"	"Detected in single"	198	"basal ganglia: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2"									"HPA043261, HPA043264, HPA044028"	Supported		Uncertain	"Nucleoli,Endoplasmic reticulum,Cytokinetic bridge"		NA	NA			"Nucleoli, Endoplasmic reticulum"	"Cytokinetic bridge"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (3.56e-1)"		"unprognostic (1.85e-1)"		"unprognostic (2.80e-1)"		"unprognostic (2.72e-2)"		"unprognostic (8.87e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"			0.0	223.2	0.0	0.8	19.8	0.0	0.0	0.0	0.0	0.0	0.5	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.6	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.4	0.0	0.0	5.1	1.9	0.0	0.0	1.2	0.2	0.1	0.1	0.7	0.0	0.0	0.0	0.8	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0
NCAPH2	"384D8-2, CAP-H2, hCAP-H2"	ENSG00000025770	"Non-SMC condensin II complex subunit H2"	Q6IBW4	22	50508216-50523472	"Predicted intracellular proteins"	"DNA condensation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA067932, HPA069056"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA067932: AB_2685926, HPA069056: AB_2686076"	"unprognostic (2.01e-1)"	"prognostic favorable (2.24e-8)"	"unprognostic (3.65e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.00e-1)"	15.7	12.4	24.5	17.8	18.8	57.4	14.7	33.5	29.4	14.5	14.2	17.4	14.6	15.6	17.5	15.7	18.0	17.2	11.4	18.2	20.0	19.6	14.5	13.8	17.0	22.2	17.8	19.2	22.8	22.6	16.3	22.0	20.0	19.0	15.2	10.8	16.8	22.4	16.6	20.2	23.2	15.7	20.5	15.7	18.4	15.7	26.1	20.4	25.2	16.3	16.8	21.0	12.0	14.5	13.7	10.1	14.5	11.6	11.3	20.9	12.8	19.9	10.8	18.9	19.3	5.6	6.5	24.5	15.8	11.0	28.6	31.2	22.0	13.8	23.1	8.7	11.3	16.0	15.9	17.2	15.1	8.3	13.2	28.5	13.3	27.4	19.7	6.9	29.4	24.0	5.9	9.5	22.6	7.6	4.3	9.2	20.2	16.7	45.0	11.5	27.5	20.1	33.6	13.4	12.0	13.0	33.8	24.6	25.4	8.3	13.1	12.3	16.1	12.4	18.5	14.8	6.3	12.7	29.0	5.9	22.4	27.0	18.3	23.4	23.5	13.1	34.2	16.8	15.1	21.0	10.6	8.4	14.5	17.1	10.4	20.9	13.7	17.7	17.4	7.0	13.2	18.7	15.5	10.2	11.3	11.6	10.1	16.8	12.8	24.5	18.8	33.5	29.4	20.0	19.6	17.8	19.2	19.0	20.4	20.8	26.9	14.1	20.2	16.8	17.5	17.1	15.3	4.0	6.8	8.7	3.9	24.7	13.3	11.3	30.7	11.3	15.5	0.0	20.2	48.4	17.3	13.7	16.2	9.5	16.9	7.9	12.6	11.1	7.2	86.8	16.1	10.9	11.8	19.8	15.5	14.5	14.9	11.5	16.3	7.0	12.9	19.4	21.2	29.6	36.4	16.2	26.3	15.8	15.6	17.6
NINL	"KIAA0980, NLP"	ENSG00000101004	"Ninein like"	Q9Y2I6	20	25452705-25585517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 20.1;Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"AF22: 14.6;Hep G2: 22.9"	"Low region specificity"	"Detected in many"							HPA000686	Uncertain		Uncertain	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Microtubules, Cytokinetic bridge, Cytosol"		"HPA000686: AB_1079193"	"unprognostic (7.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.56e-2)"	"prognostic favorable (1.47e-4)"	"unprognostic (3.39e-1)"	"prognostic favorable (1.03e-5)"	"unprognostic (3.95e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.26e-2)"	3.8	7.5	5.9	7.6	10.7	0.8	4.2	17.2	4.2	10.3	6.7	5.5	3.9	4.1	13.0	9.7	4.7	4.1	7.5	4.0	5.8	6.3	17.1	5.9	5.3	2.7	4.5	4.2	18.5	5.0	14.8	12.1	2.0	7.5	8.8	2.8	13.8	4.7	5.2	5.2	2.7	3.6	9.7	5.5	5.3	6.5	10.5	2.0	17.2	8.2	2.6	3.9	2.8	6.6	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.6	6.7	14.6	9.6	1.6	4.9	4.5	2.2	1.9	2.0	2.8	1.7	4.7	0.3	3.2	3.5	4.8	0.5	2.1	0.4	1.7	0.3	3.0	1.0	3.0	22.9	3.5	0.3	0.0	6.0	0.4	2.3	0.0	5.6	4.2	11.2	1.1	0.1	2.4	5.9	13.0	0.4	4.1	0.1	0.7	0.3	11.4	0.5	1.0	0.8	14.5	10.3	5.1	1.9	5.5	12.3	3.1	3.9	0.2	0.1	5.6	0.0	0.1	1.5	2.6	0.0	0.1	0.3	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.2	5.9	10.7	17.2	4.2	5.8	6.3	4.5	4.2	7.5	2.0	0.0	10.5	0.0	3.6	1.8	2.4	4.5	15.3	20.1	5.7	7.0	23.6	2.5	0.0	4.7	0.4	1.8	0.3	0.0	1.1	1.1	6.2	3.9	0.0	6.0	1.8	7.9	5.8	6.7	0.8	1.8	12.0	0.7	0.0	0.0	1.6	2.4	2.5	0.8	11.7	6.9	1.9	6.5	2.1	2.4	4.1	0.6	1.3	0.0	1.5	1.6
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493071	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 162.6;Peritubular cells: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	16.5	24.9	29.7	14.3	36.1	18.1	16.7	84.5	47.5	24.1	16.4	21.4	22.1	12.9	24.4	19.5	14.1	20.9	16.4	14.1	24.7	18.8	14.9	11.8	17.1	15.9	13.2	35.6	30.7	21.8	23.3	55.3	21.0	20.8	29.8	11.4	27.0	26.5	30.2	12.2	42.5	14.8	20.9	13.3	16.8	14.8	27.3	13.9	16.3	17.1	7.8	12.6	21.9	19.5	5.8	6.6	6.5	8.3	6.1	8.1	6.4	7.4	7.9	24.6	20.0	18.4	20.4	20.2	16.2	10.7	13.0	13.3	11.8	11.3	10.5	4.5	22.4	10.7	10.1	13.0	17.6	7.7	10.6	14.0	18.9	27.5	11.4	16.8	11.1	17.0	32.0	14.2	14.0	12.0	27.5	20.9	21.1	10.0	11.7	12.1	10.7	19.8	24.6	15.0	9.6	13.5	11.8	6.7	12.2	14.8	15.0	10.4	18.2	17.5	4.6	11.2	22.4	14.5	18.7	22.8	18.3	17.6	18.5	11.5	19.5	11.1	13.3	12.6	18.1	11.1	6.3	8.3	6.5	6.4	7.6	6.3	4.7	5.4	8.1	4.5	5.8	6.5	6.5	2.9	6.1	1.1	6.6	5.8	6.4	29.7	36.1	84.5	47.5	24.7	18.8	13.2	35.6	20.8	13.9	23.8	28.8	12.0	14.1	24.5	39.6	18.2	7.6	10.7	18.2	14.0	7.9	26.9	8.3	11.4	7.2	20.2	15.8	0.0	8.2	11.6	19.3	13.0	24.3	12.4	25.4	27.0	162.6	52.2	62.2	16.8	81.7	22.2	18.6	5.4	16.3	10.6	9.2	13.9	231.3	11.0	23.3	25.8	23.1	31.1	15.6	19.4	20.3	13.8	15.0	10.8
NTNG2	"KIAA1857, Lmnt2, NTNG1"	ENSG00000196358	"Netrin G2"	Q96CW9	9	132161676-132244534	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.9;brain: 32.0"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 56.2;Cone photoreceptor cells: 161.0;Rod photoreceptor cells: 109.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 4.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;HMC-1: 12.2;NB-4: 27.6;U-937: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA065089, HPA071290"	Approved		Approved	"Plasma membrane,Cytokinetic bridge,Midbody ring"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Cytokinetic bridge, Midbody ring"	"HPA065089: AB_2732730, HPA071290: AB_2686381"	"unprognostic (5.01e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.62e-2)"	"prognostic favorable (6.06e-4)"	"unprognostic (9.30e-12)"	"unprognostic (1.66e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	1.2	1.4	11.9	1.6	10.9	38.9	0.6	4.4	32.0	1.0	0.8	11.5	0.2	1.8	0.7	0.9	0.8	0.7	1.4	4.6	11.4	3.1	0.8	0.8	2.0	1.9	4.4	7.4	0.6	1.8	11.9	1.0	1.1	11.7	7.4	0.7	10.7	1.3	1.8	0.9	0.8	1.1	0.8	5.3	2.8	1.2	1.8	2.8	0.0	0.7	0.0	1.0	1.1	0.9	0.1	0.1	4.0	0.2	0.0	0.4	0.0	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.7	4.8	12.2	0.0	0.0	0.2	0.0	1.0	0.0	1.0	0.0	0.0	0.3	0.1	0.2	27.6	1.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	3.4	3.1	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.6	2.2	2.6	0.1	0.1	0.0	0.0	1.0	7.2	0.8	0.6	0.2	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.0	0.0	0.1	0.1	0.1	0.0	11.9	10.9	4.4	32.0	11.4	3.1	4.4	7.4	11.7	2.8	0.0	1.1	0.0	0.5	0.2	56.2	2.8	0.0	0.0	1.2	0.0	161.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	1.5	1.4	1.1	0.0	0.6	1.6	0.0	1.3	0.3	1.0	0.6	0.1	1.7	0.0	0.0	15.3	0.2	0.0	1.1	0.0	109.1	6.5	0.6	0.2	0.0	0.3	0.1	0.0	0.0	0.3
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 804.6;Pancreatic endocrine cells: 1519.9;Undifferentiated cells: 937.7;Urothelial cells: 2045.0"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.3;HaCaT: 21.4;OE19: 8.3;RPMI-8226: 4.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"	Yes	NA			"Nucleoplasm, Plasma membrane"	"Cytokinetic bridge, Cytosol"	"HPA077718: AB_2732358"	"prognostic favorable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	21.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.3	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3	0.0	0.0	0.0	149.7	0.1	0.0	0.4	0.0	0.0	0.0	132.6	0.0	0.0	1.7	216.4	0.2	0.0	104.8	0.0	804.6	0.0	0.0	16.5	0.0	0.0	0.1	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	18.0	135.9	3.2	1519.9	238.2	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	937.7	2045.0
OTUD7B	"CEZANNE, ZA20D1"	ENSG00000264522	"OTU deubiquitinase 7B"	Q6GQQ9	1	149937812-150010676	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"basophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;NK-cells: 1.4;T-cells: 2.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027045, HPA076357"	Supported		Uncertain	"Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA027045: AB_1854847, HPA076357: "	"unprognostic (2.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.46e-2)"	"prognostic favorable (5.09e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.58e-2)"	8.8	6.2	5.8	2.6	12.3	0.3	6.2	8.5	8.9	8.6	6.3	20.6	4.0	4.6	8.5	4.1	6.1	7.6	4.3	5.3	6.0		4.5	8.6	5.6	0.9	12.7	5.1	9.2	4.5	12.5	4.3	5.3	11.6	5.3	5.6	7.4	5.4	6.3	13.2	4.3	5.1	8.9	8.5	2.3	5.2	9.6	12.5	0.0	8.3	2.3	2.1	6.3	7.1	0.6	0.6	4.7	0.3	1.4	2.3	0.2	11.5	9.3	6.5	10.9	8.6	8.1	6.2	8.2	12.0	9.8	6.8	6.8	9.4	0.1	5.3	14.8	4.4	9.2	9.2	9.0	10.4	11.1	4.7	4.4	12.9	4.6	9.2	5.0	4.9	8.9	7.0	16.6	14.6	7.7	8.0	1.4	12.1	12.6	7.0	11.8	0.9	1.4	8.3	8.7	9.1	1.2	9.0	2.9	3.8	15.9	4.2	8.0	14.4	10.6	12.9	8.9	8.8	2.7	9.5	10.2	9.5	6.8	9.5	13.5	13.0	1.3	9.1	1.5	16.7	4.7	0.3	1.3	2.3	0.2	1.7	0.6	1.0	1.4	0.1	0.6	0.9	1.0	1.2	1.4	0.3	0.6	0.6	0.2											32.8	9.4	2.2	22.0	14.2	25.3	16.2	12.7	12.0	15.9	10.4	100.1	16.8	6.6	11.5	56.6	14.7	19.3	23.3	9.6	7.6	13.6	16.9	0.0	29.3	2.8	22.3	16.7	12.3	0.6	57.7	13.6	2.5	35.4	7.2	12.2	25.5	16.8	21.0	21.5	10.3	66.3	0.0	11.3	10.7	6.4	14.4	17.7	6.7	9.2	21.0
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;testis: 20.2"	"Group enriched"	"Detected in some"	11	"Early spermatids: 51.1;Late spermatids: 94.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"		Yes	NA			"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.5	3.1	0.2	6.4	1.4	3.9	0.2	10.6	0.2	0.2	0.1	0.0	0.1	0.3	0.9	0.2	0.2	0.3	0.3	1.9	1.0	0.3	0.1	0.4	0.3	1.7	6.9	0.2	0.2	0.1	0.7	1.0	0.2	0.5	0.1	0.0	0.3	0.6	0.1	0.7	0.1	0.2	10.5	0.3	0.1	20.2	0.0	0.1	0.4	0.0	0.3	0.4	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.2	0.0	3.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.3	1.2	0.0	5.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	6.4	0.2	10.6	1.9	1.0	1.7	6.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.4	0.0	0.0	0.0	94.3	0.6	0.0	3.3	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.5	0.0	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0
PRKACG	PKACg	ENSG00000165059	"Protein kinase cAMP-activated catalytic subunit gamma"	P22612	9	69012529-69014113	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	31	"testis: 27.4"	"Group enriched"	"Detected in some"	8	"Early spermatids: 55.1;Late spermatids: 73.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.3"									"CAB004530, HPA071185"	Supported		Uncertain	"Cytokinetic bridge,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge"	"CAB004530: AB_628137, HPA071185: AB_2686356"					"unprognostic (2.74e-1)"									"unprognostic (3.61e-2)"	"unprognostic (7.22e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.5	0.0	0.0	0.0	0.0	0.0
PRR23B	FLJ46116	ENSG00000184814	"Proline rich 23B"	Q6ZRT6	3	139019031-139020926	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	36	"testis: 4.7"	"Group enriched"	"Detected in some"	13	"Spermatocytes: 6.6;Spermatogonia: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047473	Uncertain		Uncertain	"Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Microtubules"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA047473: AB_2680062"															"unprognostic (7.57e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	4.1	0.0	0.0	0.0	0.0	0.1
PYCR3	"FLJ13852, PYCRL"	ENSG00000104524	"Pyrroline-5-carboxylate reductase 3"	Q53H96	8	143603913-143609773	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 8.1;Collecting duct cells: 14.0;Ductal cells: 7.1;Exocrine glandular cells: 7.9;Extravillous trophoblasts: 10.5;Proximal tubular cells: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053776, HPA063416, HPA069706"	Uncertain		Supported	"Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Cytosol	"Cytokinetic bridge, Mitotic spindle"	"HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178"	"unprognostic (2.12e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.54e-1)"	6.1	8.1	11.5	6.7	9.7	4.8	5.6	5.3	13.4	6.9	5.4	6.1	10.8	4.4	4.7	5.2	6.1	10.1	6.3	4.4	12.2	8.5	7.7	20.5	5.9	6.7	7.6	12.1	6.7	10.6	4.3	9.1	3.5	9.7	7.5	4.0	4.5	13.7	9.1	4.8	4.7	4.9	4.0	4.4	5.9	7.0	8.6	4.5	3.8	9.5	6.3	6.1	3.6	3.1	11.1	5.4	0.4	1.4	3.2	3.2	2.1	5.9	11.1	2.0	4.3	1.9	1.2	4.2	5.3	2.2	4.3	2.4	4.9	5.8	7.8	7.1	3.8	1.6	5.0	1.9	6.2	0.8	5.3	6.8	3.8	4.2	3.2	1.9	1.7	1.2	2.1	1.6	4.9	2.8	1.4	2.4	5.0	5.9	2.4	2.0	18.2	7.4	1.3	1.8	5.5	18.0	5.2	1.9	11.7	3.9	3.8	7.2	2.4	8.5	10.9	2.0	0.8	13.4	2.2	2.1	3.8	8.0	5.9	4.9	4.2	1.0	4.9	4.5	2.4	3.5	0.3	1.4	0.2	3.2	1.1	3.1	5.8	2.1	2.6	2.1	11.1	3.0	3.0	0.4	3.2	1.0	5.4	1.8	2.1	11.5	9.7	5.3	13.4	12.2	8.5	7.6	12.1	9.7	4.5	3.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.2	14.0	0.0	4.9	3.3	7.1	0.0	0.0	0.0	0.0	7.9	10.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	6.1	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
SNPH	bA314N13.5	ENSG00000101298	Syntaphilin	O15079	20	1266316-1309328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.2"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 19.5;Horizontal cells: 28.6;Rod photoreceptor cells: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.5;naive CD8 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049393	Approved		Uncertain	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA049393: AB_2680744"	"unprognostic (1.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (1.03e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.21e-1)"	2.9	5.0	26.7	3.0	22.5	1.6	1.8	14.4	36.2	3.5	3.5	3.1	5.9	3.1	4.5	3.9	3.6	4.7	4.8	4.7	26.8	15.3	2.1	0.9	2.6	3.1	12.8	17.5	2.4	6.1	6.2	5.8	1.7	17.1	5.5	2.2	3.1	9.9	19.2	6.1	1.9	3.1	8.1	3.8	2.1	5.1	2.7	4.4	0.1	4.5	0.1	2.0	3.6	1.6	0.1	0.4	0.0	0.0	0.0	3.5	1.2	2.2	6.6	0.1	6.7	8.0	4.4	0.0	4.0	5.3	4.5	2.1	0.2	0.7	0.4	2.4	4.9	11.2	1.2	1.0	5.7	0.8	1.4	1.8	4.2	1.1	0.1	4.2	0.0	6.9	2.8	2.8	4.5	0.9	4.5	5.7	4.5	0.8	0.2	4.1	0.0	0.4	0.2	2.4	0.0	5.6	0.0	1.4	0.1	6.0	3.2	0.4	2.0	3.9	0.2	5.8	0.7	0.3	0.1	9.7	7.3	5.4	6.4	1.1	0.6	1.2	0.0	3.9	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.1	0.8	0.9	0.1	0.1	3.5	3.2	0.0	0.0	0.0	0.4	0.4	1.2	26.7	22.5	14.4	36.2	26.8	15.3	12.8	17.5	17.1	4.4	0.0	0.0	0.0	0.1	0.1	19.5	4.3	5.1	0.0	0.0	3.5	5.9	0.0	0.0	0.4	8.3	0.6	0.0	0.0	0.5	0.0	0.8	0.9	0.0	0.0	0.2	28.6	8.1	1.8	0.0	3.2	1.4	0.0	0.0	0.0	0.9	2.9	1.7	0.0	3.9	1.3	19.9	6.5	1.0	0.6	0.1	0.1	0.0	0.0	1.3	0.0
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	12.4	33.4	32.3	8.4	33.3	10.1	20.4	19.9	43.5	31.3	13.1	23.0	20.1	10.9	24.4	30.4	12.0	34.5	17.2	18.4	31.2	35.9	25.7	21.8	18.2	13.4	24.2	29.4	32.8	36.0	20.2	19.0	12.3	23.0	25.9	11.3	28.3	26.3	22.0	15.9	11.0	9.5	16.6	17.0	9.4	15.2	22.2	12.2	7.8	30.7	7.0	10.8	17.6	14.9	28.0	29.3	21.2	32.7	15.1	36.8	37.2	15.0	28.5	18.1	41.8	9.8	14.0	32.1	11.9	12.7	19.0	17.2	27.9	24.5	8.0	17.4	17.8	17.6	30.2	18.9	19.5	9.4	5.1	32.5	13.9	46.0	18.2	18.9	6.6	13.0	16.6	21.7	17.7	10.8	23.0	11.7	11.3	24.8	8.8	16.3	19.3	8.0	10.9	27.6	13.8	70.5	14.5	27.0	10.4	21.8	11.7	16.9	34.5	21.2	36.4	21.9	28.2	44.7	11.7	8.7	21.4	17.8	17.0	14.3	36.2	31.1	6.1	16.2	7.2	10.3	19.1	32.7	16.9	25.5	20.9	28.7	28.0	24.8	20.9	26.9	27.0	36.8	24.2	21.2	15.1	18.9	29.3	21.5	37.2	32.3	33.3	19.9	43.5	31.2	35.9	24.2	29.4	23.0	12.2	47.6	38.0	4.5	30.3	11.4	64.1	33.1	48.4	54.9	40.9	34.9	29.5	35.6	14.9	74.6	47.8	25.3	7.4	0.0	65.8	41.2	50.3	37.0	12.7	32.1	24.1	7.9	30.6	29.4	15.0	47.1	65.6	14.5	21.9	11.8	25.4	102.0	41.4	18.2	49.8	48.1	26.0	12.9	32.0	44.2	81.2	12.2	10.9	12.8	28.5	22.0
VLDLR	"CARMQ1, CHRMQ1, VLDLRCH"	ENSG00000147852	"Very low density lipoprotein receptor"	P98155	9	2621834-2660053	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 50.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 72.2;Cone photoreceptor cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 14.1"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 14.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 27.2;JURKAT: 21.2;THP-1: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032462, HPA051312"	Uncertain		Uncertain	"Vesicles,Cytokinetic bridge,Centriolar satellite"		NA	NA		180000	Vesicles	"Cytokinetic bridge, Centriolar satellite"	"CAB032462: AB_2216805, HPA051312: "	"unprognostic (5.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (5.95e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.34e-2)"	11.3	13.7	7.2	3.7	9.6	1.3	11.2	8.7	7.3	6.9	3.9	12.8	6.5	1.2	12.1	4.3	11.6	15.1	5.5	38.0	7.6	4.5	8.8	2.5	6.9	0.9	13.2	5.3	50.5	20.8	43.6	5.9	9.4	7.7	5.7	2.9	12.3	7.5	4.4	21.2	3.4	1.6	15.7	10.1	5.5	5.8	5.6	10.3	0.0	8.8	12.5	3.9	11.9	6.1	0.1	0.8	14.1	0.1	0.1	1.1	0.0	0.0	2.9	18.8	0.8	2.8	0.2	27.2	8.5	2.8	2.2	6.5	4.7	0.3	0.0	9.2	5.2	1.4	0.2	5.2	5.7	7.3	9.9	1.9	0.1	2.5	2.2	3.0	11.8	2.1	1.2	4.2	0.8	0.4	9.7	1.1	21.2	0.0	16.7	1.3	0.8	2.1	1.6	9.5	1.5	1.1	0.2	0.6	0.0	10.9	1.1	4.2	3.0	0.6	0.9	11.8	14.2	0.4	28.0	0.3	3.1	5.8	0.0	5.6	12.7	5.1	3.0	20.2	9.9	1.1	0.1	0.1	14.1	0.2	0.0	1.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	2.0	0.1	0.0	0.8	0.0	0.0	7.2	9.6	8.7	7.3	7.6	4.5	13.2	5.3	7.7	10.3	14.9	9.1	0.0	1.0	2.4	17.9	72.2	2.5	8.1	2.3	5.2	98.2	11.4	1.7	10.1	4.5	2.7	0.9	0.0	8.9	18.7	14.0	5.0	0.0	1.3	2.1	11.1	10.5	1.3	0.3	1.9	7.2	0.6	10.1	1.8	0.3	2.7	11.2	2.6	10.3	4.4	30.4	0.0	10.3	1.5	7.0	1.8	2.9	1.8	0.6	3.0
